Inventory decreased 59.0%
Inventory changed -59.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory changed -59.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed +95.4% from the comparable as-filed period. The change ranks at the 100th percentile of 7 prior comparable changes.
Total assets changed -78.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed -74.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed -50.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -7474 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -68.6% from the comparable as-filed period.
Current ratio changed -48.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed -7098 basis points from the comparable as-filed period.
Operating cash flow changed -201.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross margin changed -8994 basis points from the comparable as-filed period.
Inventory / revenue changed -6736 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Research & development changed -95.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Trade receivables changed +96.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -17.1% from the comparable as-filed period.
Revenue changed -12.9% from the comparable as-filed period.
Receivables / revenue changed +1691 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Cost of revenue changed -18.4% from the comparable as-filed period.
Operating cash-flow margin changed -45487 basis points from the comparable as-filed period.
Working capital changed +18.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
R&D / revenue changed -211 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed -8317.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.